-
2
-
-
4444293411
-
A review of cohort studies on the association between history of diabetes mellitus and occurrence of cancer
-
Mori M, Saitoh S, Takagi S, Obara F, Ohnishi H, Akasaka H, Izumi H, Sakauchi F, Sonoda T, Nagata Y, Shimamoto K,. A review of cohort studies on the association between history of diabetes mellitus and occurrence of cancer. Asian Pac J Cancer Prev 2000; 1 (4): 269 -276.
-
(2000)
Asian Pac J Cancer Prev
, vol.1
, Issue.4
, pp. 269-276
-
-
Mori, M.1
Saitoh, S.2
Takagi, S.3
Obara, F.4
Ohnishi, H.5
Akasaka, H.6
Izumi, H.7
Sakauchi, F.8
Sonoda, T.9
Nagata, Y.10
Shimamoto, K.11
-
3
-
-
0029017953
-
Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis
-
Everhart J, Wright D,. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 1995; 273 (20): 1605 -1609.
-
(1995)
JAMA
, vol.273
, Issue.20
, pp. 1605-1609
-
-
Everhart, J.1
Wright, D.2
-
4
-
-
33750930105
-
Diabetes mellitus and risk of bladder cancer: A meta-analysis
-
Larsson SC, Orsini N, Brismar K, Wolk A,. Diabetes mellitus and risk of bladder cancer: A meta-analysis. Diabetologia 2006; 49 (12): 2819 -2823.
-
(2006)
Diabetologia
, vol.49
, Issue.12
, pp. 2819-2823
-
-
Larsson, S.C.1
Orsini, N.2
Brismar, K.3
Wolk, A.4
-
5
-
-
34249948987
-
Diabetes mellitus and risk of endometrial cancer: A meta-analysis
-
DOI 10.1007/s00125-007-0681-5
-
Friberg E, Orsini N, Mantzoros CS, Wolk A,. Diabetes mellitus and risk of endometrial cancer: A meta-analysis. Diabetologia 2007; 50 (7): 1365 -1374. (Pubitemid 46879010)
-
(2007)
Diabetologia
, vol.50
, Issue.7
, pp. 1365-1374
-
-
Friberg, E.1
Orsini, N.2
Mantzoros, C.S.3
Wolk, A.4
-
6
-
-
34547127614
-
Diabetes mellitus and risk of breast cancer: A meta-analysis
-
DOI 10.1002/ijc.22717
-
Larsson SC, Mantzoros CS, Wolk A,. Diabetes mellitus and risk of breast cancer: A meta-analysis. Int J Cancer 2007; 121 (4): 856 -862. (Pubitemid 47106217)
-
(2007)
International Journal of Cancer
, vol.121
, Issue.4
, pp. 856-862
-
-
Larsson, S.C.1
Mantzoros, C.S.2
Wolk, A.3
-
7
-
-
27944450832
-
Diabetes mellitus and risk of colorectal cancer: A meta-analysis
-
DOI 10.1093/jnci/dji375
-
Larsson SC, Orsini N, Wolk A,. Diabetes mellitus and risk of colorectal cancer: A meta-analysis. J Natl Cancer Inst 2005; 97 (22): 1679 -1687. (Pubitemid 41672234)
-
(2005)
Journal of the National Cancer Institute
, vol.97
, Issue.22
, pp. 1679-1687
-
-
Larsson, S.C.1
Orsini, N.2
Wolk, A.3
-
8
-
-
67650874081
-
Cancer statistics
-
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics. CA Cancer J Clin 2009; 59 (4): 225 -249.
-
(2009)
CA Cancer J Clin
, vol.59
, Issue.4
, pp. 225-249
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Thun, M.J.6
-
9
-
-
3142729250
-
Diabetes mellitus and risk of prostate cancer: A meta-analysis
-
Bonovas S, Filioussi K, Tsantes A,. Diabetes mellitus and risk of prostate cancer: A meta-analysis. Diabetologia 2004; 47 (6): 1071 -1078.
-
(2004)
Diabetologia
, vol.47
, Issue.6
, pp. 1071-1078
-
-
Bonovas, S.1
Filioussi, K.2
Tsantes, A.3
-
10
-
-
33845328853
-
A meta-analysis of diabetes mellitus and the risk of prostate cancer
-
DOI 10.1158/1055-9965.EPI-06-0410
-
Kasper JS, Giovannucci E,. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15 (11): 2056 -2062. (Pubitemid 44877026)
-
(2006)
Cancer Epidemiology Biomarkers and Prevention
, vol.15
, Issue.11
, pp. 2056-2062
-
-
Kasper, J.S.1
Giovannucci, E.2
-
11
-
-
70350433657
-
The protective effect of diabetes mellitus against prostate cancer: Role of sex hormones
-
Baradaran N, Ahmadi H, Salem S, Lotfi M, Jahani Y, Mehrsai AR, Pourmand G,. The protective effect of diabetes mellitus against prostate cancer: Role of sex hormones. Prostate 2009; 69 (16): 1744 -1750.
-
(2009)
Prostate
, vol.69
, Issue.16
, pp. 1744-1750
-
-
Baradaran, N.1
Ahmadi, H.2
Salem, S.3
Lotfi, M.4
Jahani, Y.5
Mehrsai, A.R.6
Pourmand, G.7
-
12
-
-
60549106435
-
Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study
-
Kasper JS, Liu Y, Giovannucci E,. Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer 2009; 124 (6): 1398 -1403.
-
(2009)
Int J Cancer
, vol.124
, Issue.6
, pp. 1398-1403
-
-
Kasper, J.S.1
Liu, Y.2
Giovannucci, E.3
-
13
-
-
45749116179
-
Diabetes mellitus and prostate cancer risk
-
Pierce BL, Plymate S, Ostrander EA, Stanford JL,. Diabetes mellitus and prostate cancer risk. Prostate 2008; 68 (10): 1126 -1132.
-
(2008)
Prostate
, vol.68
, Issue.10
, pp. 1126-1132
-
-
Pierce, B.L.1
Plymate, S.2
Ostrander, E.A.3
Stanford, J.L.4
-
14
-
-
23844528527
-
History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States)
-
Chan JM, Latini DM, Cowan J, Duchane J, Carroll PR,. History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States). Cancer Causes Control 2005; 16 (7): 789 -797.
-
(2005)
Cancer Causes Control
, vol.16
, Issue.7
, pp. 789-797
-
-
Chan, J.M.1
Latini, D.M.2
Cowan, J.3
Duchane, J.4
Carroll, P.R.5
-
15
-
-
74549196089
-
Diabetes and outcomes after radical prostatectomy: Are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database
-
Jayachandran J, Aronson WJ, Terris MK, Presti JC Jr, Amling CL, Kane CJ, Freedland SJ,. Diabetes and outcomes after radical prostatectomy: Are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database. Cancer Epidemiol Biomarkers Prev 2010; 19 (1): 9 -17.
-
(2010)
Cancer Epidemiol Biomarkers Prev
, vol.19
, Issue.1
, pp. 9-17
-
-
Jayachandran, J.1
Aronson, W.J.2
Terris, M.K.3
Presti, Jr.J.C.4
Amling, C.L.5
Kane, C.J.6
Freedland, S.J.7
-
16
-
-
65549118658
-
Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer
-
Hong SK, Lee ST, Kim SS, Min KE, Byun SS, Cho SY, Choe G, Lee SE,. Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer. Prostate 2009; 69 (8): 820 -826.
-
(2009)
Prostate
, vol.69
, Issue.8
, pp. 820-826
-
-
Hong, S.K.1
Lee, S.T.2
Kim, S.S.3
Min, K.E.4
Byun, S.S.5
Cho, S.Y.6
Choe, G.7
Lee, S.E.8
-
17
-
-
48149094205
-
Hormonal profile of diabetic men and the potential link to prostate cancer
-
Kasper JS, Liu Y, Pollak MN, Rifai N, Giovannucci E,. Hormonal profile of diabetic men and the potential link to prostate cancer. Cancer Causes Control 2008; 19 (7): 703 -710.
-
(2008)
Cancer Causes Control
, vol.19
, Issue.7
, pp. 703-710
-
-
Kasper, J.S.1
Liu, Y.2
Pollak, M.N.3
Rifai, N.4
Giovannucci, E.5
-
18
-
-
33644981693
-
Sex differences of endogenous sex hormones and risk of type 2 diabetes: A systematic review and meta-analysis
-
Ding EL, Song Y, Malik VS, Liu S,. Sex differences of endogenous sex hormones and risk of type 2 diabetes: A systematic review and meta-analysis. JAMA 2006; 295 (11): 1288 -1299.
-
(2006)
JAMA
, vol.295
, Issue.11
, pp. 1288-1299
-
-
Ding, E.L.1
Song, Y.2
Malik, V.S.3
Liu, S.4
-
19
-
-
55449101667
-
Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction
-
El-Sakka AI, Sayed HM, Tayeb KA,. Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction. Int J Androl 2008; 31 (6): 602 -608.
-
(2008)
Int J Androl
, vol.31
, Issue.6
, pp. 602-608
-
-
El-Sakka, A.I.1
Sayed, H.M.2
Tayeb, K.A.3
-
20
-
-
33745684473
-
Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes
-
Kapoor D, Goodwin E, Channer KS, Jones TH,. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2006; 154 (6): 899 -906.
-
(2006)
Eur J Endocrinol
, vol.154
, Issue.6
, pp. 899-906
-
-
Kapoor, D.1
Goodwin, E.2
Channer, K.S.3
Jones, T.H.4
-
21
-
-
0033950926
-
Is low serum free testosterone a marker for high grade prostate cancer?
-
Hoffman MA, DeWolf WC, Morgentaler A,. Is low serum free testosterone a marker for high grade prostate cancer? J Urol 2000; 163 (3): 824 -827.
-
(2000)
J Urol
, vol.163
, Issue.3
, pp. 824-827
-
-
Hoffman, M.A.1
Dewolf, W.C.2
Morgentaler, A.3
-
22
-
-
0344406150
-
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy
-
Massengill JC, Sun L, Moul JW, Wu H, McLeod DG, Amling C, Lance R, Foley J, Sexton W, Kusuda L, Chung A, Soderdahl D, Donahue T,. Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J Urol 2003; 169 (5): 1670 -1675.
-
(2003)
J Urol
, vol.169
, Issue.5
, pp. 1670-1675
-
-
Massengill, J.C.1
Sun, L.2
Moul, J.W.3
Wu, H.4
McLeod, D.G.5
Amling, C.6
Lance, R.7
Foley, J.8
Sexton, W.9
Kusuda, L.10
Chung, A.11
Soderdahl, D.12
Donahue, T.13
-
23
-
-
18744369944
-
Testosterone as a predictor of pathological stage in clinically localized prostate cancer
-
Isom-Batz G, Bianco FJ Jr, Kattan MW, Mulhall JP, Lilja H, Eastham JA,. Testosterone as a predictor of pathological stage in clinically localized prostate cancer. J Urol 2005; 173 (6): 1935 -1937.
-
(2005)
J Urol
, vol.173
, Issue.6
, pp. 1935-1937
-
-
Isom-Batz, G.1
Bianco, Jr.F.J.2
Kattan, M.W.3
Mulhall, J.P.4
Lilja, H.5
Eastham, J.A.6
-
24
-
-
13844299328
-
Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy
-
Imamoto T, Suzuki H, Fukasawa S, Shimbo M, Inahara M, Komiya A, Ueda T, Shiraishi T, Ichikawa T,. Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy. Eur Urol 2005; 47 (3): 308 -312.
-
(2005)
Eur Urol
, vol.47
, Issue.3
, pp. 308-312
-
-
Imamoto, T.1
Suzuki, H.2
Fukasawa, S.3
Shimbo, M.4
Inahara, M.5
Komiya, A.6
Ueda, T.7
Shiraishi, T.8
Ichikawa, T.9
|